South Carolina Medicaid approved GLP-1s to treat obesity, placing it among the few state programs covering the drugs. But ...

A cross-sectional study showed that rates of metabolic and bariatric surgery increased by almost 15% from 2021 to 2023 among ...

Research shows intentional weight loss in older adults can lead to better mobility, reduced medical complications, and ...

Northern Ireland's first regional obesity management service has been approved by the health minister. Mike Nesbitt's ...

Obesity causes temporary disruptions, but not permanent structural changes, in the liver’s molecular network that regulates ...

A major new meta-analysis from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London has ...

Weightwatchers and bariatric surgery had limited effects on the obese brain, but GLP-1s like Ozempic may mean new hope in ...

The standards represent the American Diabetes Association’s effort to address the stigma that affects healthcare access, ...

Researchers examined the heritability of body mass index (BMI), highlighting that genetics and the gut microbiome both play major roles in obesity risk. The review emphasizes that maternal microbiome ...

Obesity medications in development could improve accessibility and affordability, according to a presenter at Obesity Medicine 2025.The use of GLP-1 receptor agonists and other weight-loss medications ...

It's well-known that obesity is a risk factor for cardiovascular disease. But some research suggests that while people who ...

Researchers analyzing data from 915 U.S. cities found that both obesity and impulsivity (measured by ADHD rates) are less ...